• 検索結果がありません。

1C 6 0d F03 /%vh

N/A
N/A
Protected

Academic year: 2021

シェア "1C 6 0d F03 /%vh"

Copied!
87
0
0

読み込み中.... (全文を見る)

全文

(1)

/ 5

0 2

(2)

Intensive Care Med. 2019;45:1783

(3)

2 T e B 3

8 0 1 / 69

7 B % I % I5

7 B

MMWR Surveill Summ. 2017;66(9):1

I )( I % I5

B

http://www.cdc.gov/traumaticbraininjury/severe.html J Neurol Neurosurg Psychiatry.2011;82:931

(4)

9

1 6 8

(5)

1 st edition 2 nd edition

3 rd edition

4 th edition

Guidelines for the Management of Severe Traumatic Brain Injury

4th Edition

t Va

e

T g

M aP

d A

blaP n n BD c aP

T T r T

t CI

o e ) d e ))

0 2 ) 1 07 9 9 5

t

ie (

o e ) d e ))

0 2 ) 1 07 9 9 5

t Va t CI

t

(6)

T

I

I

B

(7)

Intensive Care Med. 2019;45:1783

(8)

p A

o I P Dh

e D D aC r )

Dt i

m CT Bg

T B g

)) )

s A lC D )( (

(9)
(10)
(11)

p

h D

l

i e

(12)

Consensus Working

Group

(13)

OB

I 0

1 C 0

(14)

0 010 1

3 5 2 54

(15)

8 P

C I H 8

(16)

0 5 75 1 5 7 7 94 7 15 5297 5 7 5 I

B C B C

(17)

R

0 03

8

E a

% 8

(18)

Treatment Question

Blinded Voting

80 %

Agreement

NO YES

Discussion

CONSENSUS!!

Recommendation

(19)
(20)

Tier Zero

Tier One

Tier Two

Tier Three

Not recommend Inter tier

Neuroworsening Heat map

(21)

I 3

P

e C

I 3 R

e P

(22)
(23)

S m

9 H Hd

b

2 g8 PL

p C // % 66

3 4

I EO V U

07 tPL

(24)

b p

9 P S

28 V L

I

// % 66 3 4

O U E

b g V L

07

d t

/ C m H

(25)
(26)

H 5 i g e O 5

PB

5C P

5C a

23 2 00 22 9 P 5

5C a

5C a

(27)

0 1 0 1 4

NO .2- .2 - C E

.2 - 55 3

IH :

(28)

8 HBCL :CM IF 5CA0 / ( . 974/ +. +

LDC :127 6 L F CNC C 27

cO 3 O (

n R .n+

7 u P((S 27 o ( S )-rt O S Dla

veh b i T

3 HI ILDC P( S

; +m s u s

(29)

26 89 49 9 -

531. ) )(

0D :9 ;6 IH

P L M N ( F :

(30)

6181 - 4 )0( /

;854/ ( ( ++

A ;:71 B C

; hm T I 25 atr 3 ).

cM c

5 h i (( ( N

O PRs

DC L il

e N AR53; P ( N R

3 9 D A DB ( J N : o + c Tv h

(31)

1.2. 54 -

320 ( ))

MD 78 (: 6

P) A A I J ;

(32)

3

(33)

3

C I 3

(34)

3

(35)

3

(36)

Tier One

(37)

Tier One

C O

F I O

S

2HP O

(38)

Tier One

11 66,5

1L HE

1L HE

1 0 F

S66,5E

m E

2 T P

T E

E L

OL

3 N T BEIEL a 1 66,5 11 66,5

F/ 6 6

L C BEgaLq

(39)

Tier Two

(40)

Tier Two

Cn 11

C h C) a A

m

( HA H

l g p C

) / 00 2 e IC

) 11 C

P M OM

(41)

ICP

MAP CPP

CPP MAP−ICP

CPP cerebral perfusion pressure ICP intracranial pressure

(42)

B 8

J Neurosurg. 2001 ;95:222

%

% 7A

% 7A

(43)

CBV cerebral blood volume PRx pressure reactivity index

(44)

CBV cerebral blood volume PRx pressure reactivity index

(45)

C0 )

M ( H

) A

) /I

) /I

P

I 2 1

I 2 1 H

(46)

m TR V C gM5 0 V F 22 1H FVg

I 0 A B

J Neurosurg. 2011 ;114:62

3 P F

(47)

Tier Three

( 6 )

(

5 5

5 3 -

) 5 -

(48)

9 4 BE 7 8 ) 3 + + ) . (

;863. (((

C 4 JH C J ) JD>E

; 16 62;0 5B da

cN(+ N +da

-T O (T

6 5MIH C J D> )P > >J >J 2 > >J >J

: S

(49)

H 6

C PI 6/

(50)

H r an t vsc iy S H hm os

H I

H > < yg lpagS

H p eI.5-5S

H K S2/4+ >> S

HH

I n g 3

H 2/4+ >> K P K S

H 3

H2/4H p k m 08 >AB8CC 8 /B6 8 D >

A D 8B> 6 4B D

(51)

n nkyI m I t

s l

K I I I

> r kr

oK.6-6

2/4 hc

R P

K I y rI 3 I

I I I I I eS

2/4 I < I+ c

I I I 3 I I

2/4+ h I

v I0 B CD /D8A B Hi

5/ T p g

HCB < 8 e P

Pa

rPa

a a

(52)
(53)

S

s

CG I

CG o N

/ e

/t/ I

/ / / / /

/ / m / 1 /

/ Pm /

/ / / / /

S c r

(54)

m

e a C

h

T e

/

(55)

2 5

-- 3 D aI

-- 3 c 3 -

M N > <

-- 3 d 3 -

M N > <

-- 3 e 3 -

M N > <

3 f L > E M N

3 3 L < M N

J Neurotrauma. 1992 ;1:S287

(56)

/

4 4

) 4 +) 4

(

- > C 1 4166 I261 53521 587 MP

(57)

- - ) - +) -

(

1

(58)

-

(

- -

) - +) -

2 3

(59)

G C P e

i dI W

T

a h

S

a h

(60)

/

(

4

4 ) 4

+) 4

1 4166 261 53521 587

- > C

I

(61)

1

(

-

- ) - +) -

(62)

-

(

-

- ) - +) -

2 3

(63)

t D PO E l M

- E n - )

Mc

bErh - - ) - - -

( C imaEd Mo p

( s g MI D

DMv E M) rh eEi

(64)

2 C

B

I T

4 S 4

(65)

4 03 H

4 03 < 7

4 03 ., C > I

4 03 ., P 6., 22-1 , 22-1

(66)

/ 1 %% . 3 -/H 1/ % IN

> 6< ok P s

e

T S mp

rg e

> 6< a

2- V V t

w lC % > /

% 05 IN mp

T C %

% F > 5 5< IN

% mp

(67)

- -

(68)

6 2E C 4 1 +.( + - )+ , 8 31- ( ())+

J 2:; ; 38 J B C 8 ; 3 u

NosmN 0;N( ) uN ) P )

3 308 D EBJ

0 CBEB C DBE JB E ECM hld 0; T

7 D IBJ J D

e xyt ( ac hign

308 D EBJ r pSRO

(69)
(70)
(71)

1G: 6 N 6 I C O:I

8 G 9G: C:I < 1G: 4 GN 7 : I 16689

529 ( ) ) II / <B <:BIG :B <I

I 16689

7 G 914 3280- .)

) y .c-e (c e m 7 I6 427 P z

rwg+ htjS l

4 427 7 I6 T puT bh 2 427 BN T

6 s +aegTxnoivg

(72)

5 357 93 063 32 05

: C 1 .

P OM J I

: C 1 . J

: 1 . D

(73)

2

(74)

Tier Zero

Tier One

Tier Two

Tier Three

Not recommend Inter tier

Neuroworsening

(75)

2

2 2

(76)

2

2 2

(77)

00 5P - 0 I M

- 0 I M

gn l

1 ma m n

n

03 / P

5

g l O 03 / 5

- 2 P OUS O

O )0 00 M -- p

A- 0 I M P 00

O p

3 63 5 p O

)0 5 P FHO

h n p

le m g l O (

03 /C 5 M

(78)

3 m

i

He C

1 I I

T

1 -

22 0 P OI

i P - baHg B O

(79)

2

2 2

(80)

> 11 ( -6 P

> S O CF 77 3 M

> 0 77 3C

>1 0 O 5 M IS 1 0 H

> bln

> 0 C 77 3 M

> 1 -6 M

> 2 me a

>p S1 0 M

>1 0

>t / 1 11 -09 40662 32

/ 7 5 65 C

/ 1 -6A

g h b bln C

>/ 1 mna 1 0 M 11 M

> S O 11 ( -6 M

> 0 % 77 3

>1 0 ) -6

>1 0 S 11 / 1 1 0 -6 SF 1 H

(81)

3 ) ) el 1 m

1 t T C

5 v 1 v T

ya Ibi

F

53 I 5 OI

53 I 0 OI

53 % F

0) v g

1 t )

v d

pr 2365 3 PT I t H T

(82)

2

2 2

(83)

-- 1 P

S O )//

)/ H /2 %M )/ H /2 %

n i t mm bb

- 1

)0 g h a g

pi

/1 % O

6 % M IS /1 % H

- 1> M

)/S/2 %

/2 % S )/

1 ) 177 C

(/ A %

pi C

(/ )// 6 2 330510

(/ a /2 % )/ )//

S O )// M

tle - 1

/1 %S)// (/ /2 % %

SF 7 9 C

(84)

1C 6 0d F03 /%vh

/% ( d

03 /% d s IH t l

1 6 %Tgm 02/%

r

1 6 0 32 65T T

6 32 3 2 6 6 2 p i To e

0 h P 00 n D

OT T y /% 56 6 C a bc

(85)
(86)

5 e at rsup i5

P i

5 B i

5 o

23 2 00 22 gm PC5

5 5

n OH 5 9 2

n o 9

(87)

2 -2- /2Rl

Sd b rh R n P C P

- g /- 2

e a eF

oI mP

pi tO P

n F O P T h

P I P F C P

参照

関連したドキュメント

gambiae and Anopheles arabiensis Patton bite humans sleeping outdoors (Faye et al. 1997), and such human habits may inßuence the biting behavior of the mosquitoes... Here, we

201 Tl distribution inhibiting the Sol antigravitational activation. However factors other than muscle activity may be involved in low blood perfusion seen in Sol of the U3w group.

prove that the cbv linear β-template is robust and safe … relative to arithmetic and cbv linear β-reduction. apply the Partial Characterisation Theorem Partial

Other important features of the model are the regulation mechanisms, like autoregulation, CO 2 ¼ reactivity and NO reactivity, which regulate the cerebral blood flow under changes

In this paper we establish the Aleksandrov-Fenchel type inequality for volume differences function of convex bodies and the Aleksandrov-Fenchel inequality for

Massoudi and Phuoc 44 proposed that for granular materials the slip velocity is proportional to the stress vector at the wall, that is, u s gT s n x , T s n y , where T s is the

The finite element method is used to simulate the variation of cavity pressure, cavity volume, mass flow rate, and the actuator velocity.. The finite element analysis is extended

Assuming an inversely proportional scaling of ESR with case volume, reaping the volume reduction afforded by higher switching frequency affects the output ripple voltage of